Table 1.

Clinical information of COVID-19 patients.

Sample ID	Type	Days from symptom onset to antibody test	Treatment	Days of nucleic acid positive-to-negative conversion	Days of re-detectable positive nucleic acid from symptom onset
P1	Severe	10,17,55	C+A+G	10	N/A
P2	Severe	11,18,34	C+A+G	13	N/A
P3	Severe	9,24,35,44	C+A+G	15	N/A
P4	Severe	18,27,33	C+A	12	N/A
P5	Severe	18,24,36,54,61	C	29	30
P6	Mild	14,20,29,42,49	C+A	29	N/A
P7	Mild	14,20,28,41	C+A	22	21
P8	Mild	6,13,18	A	6	N/A
P9	Mild	13,27,41,49,56	C+A	15	N/A
P10	Mild	9,16,45,52	C+A	16	N/A
P11	Mild	5,14,38,44	C+A	16	N/A
P12	Mild	11,20,38	A	8	N/A
P13	Mild	2,9,16,44,55	C+A	11	N/A
P14	Mild	8,15,22,31,41	C+A+G	22	17
P15	Mild	11,17,47,54	C+A	32	N/A
P16	Severe	17,21,52	C+A+G	8	N/A
P17	Severe	8,16	C+A	9	N/A
P18	Severe	13,19	C+A	11	N/A
P19	Severe	11,17	C+A	10	N/A
P20	Severe	15,22,27	C+A	11	N/A
P21	Severe	5,41	N/A	4	N/A
P22	Mild	15,41,63	A	15	14
P23	Mild	30,41,47	C+A	27	25
P24	Mild	40,48	C	6	N/A
P25	Mild	51,58	C+A	20	37
P26	Mild	7,21,29	C+A	1	N/A
P27	Mild	14,28	C+A	1	N/A
P28	Mild	7,28	C	5	N/A
P29	Mild	6,19,27	C	2	N/A
P30	Mild	25,43,49	C	33	26
P31	Mild	17,21,50	C+A	13	N/A
P32	Mild	45,51	A	11	N/A
P33	Mild	5,10,20	C	N/A	N/A
P34	Mild	7,14	C	1	N/A
P35	Mild	16,48	A	12	N/A
P36	Mild	12,35,42	C+A	8	N/A

C, Chloroquine; A, Anti-viral drugs(Lopinavir/ritonavir or Arbidol); G, Glucocorticoid; P, patient; N/A, not applicable. Days of nucleic acid positive-to-negative conversion is calculated from the time of admission.